Chargement en cours...
Safety of Spironolactone Use in Ambulatory Heart Failure Patients
BACKGROUND: Since the Randomized Aldactone Evaluation Study (RALES), the use of spironolactone is recommended in systolic heart failure (HF) patients that have been in New York Heart Association (NYHA) class III or IV. There is limited information on the use, side effects, and withdrawal rate of spi...
Enregistré dans:
| Publié dans: | Clin Cardiol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley Periodicals, Inc.
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652974/ https://ncbi.nlm.nih.gov/pubmed/19006114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20284 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|